Travere Therapeutics, Inc. (TVTX)

NASDAQ: TVTX · Real-Time Price · USD

58.85

-0.18 (-0.30%)

At close: Jun 26, 2026, 4:00 PM EDT

60.19

+1.34 (2.28%)

After-hours: Jun 26, 2026, 6:33 PM EDT

Travere Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	5,473	3,474	1,523	678	1,352	1,940
Market Cap Growth	324.43%	128.05%	124.84%	-49.89%	-30.30%	36.22%
Enterprise Value	5,536	3,480	1,554	515.48	1,309	1,649
Last Close Price	58.85	38.21	17.42	8.99	21.03	31.04
Forward PE	24.94	38.08	-	-	-	-
PS Ratio	10.21	7.08	6.53	4.67	12.35	14.71
PB Ratio	55.08	30.26	25.79	3.37	31.55	6.42
P/TBV Ratio	-	3550.82	-	6.93	-	12.09
P/FCF Ratio	138.16	91.95	-	-	-	-
P/OCF Ratio	138.16	91.95	-	-	-	-
EV/Sales Ratio	10.32	7.09	6.67	3.55	11.96	12.51
EV/FCF Ratio	139.75	92.11	-	-	-	-
Debt / Equity Ratio	3.26	2.81	5.54	1.99	9.41	0.85
Debt / EBITDA Ratio	20.36	-	-	-	-	-
Debt / FCF Ratio	8.30	8.70	-	-	-	-
Net Debt / Equity Ratio	0.64	0.05	0.52	-0.81	-1.00	-0.96
Net Debt / EBITDA Ratio	3.91	-2.85	-0.11	0.46	0.14	1.56
Net Debt / FCF Ratio	1.60	0.16	-0.13	0.58	0.23	14.62
Asset Turnover	0.92	0.82	0.34	0.20	0.15	0.19
Inventory Turnover	0.25	0.31	0.23	0.64	0.75	0.51
Quick Ratio	2.81	2.52	1.98	3.31	3.28	4.58
Current Ratio	3.13	2.74	2.08	3.47	3.42	4.70
Return on Equity (ROE)	-34.75%	-57.80%	-246.75%	-308.90%	-192.18%	-84.66%
Return on Assets (ROA)	-9.81%	-10.69%	-46.85%	-53.15%	-44.18%	-28.87%
Return on Invested Capital (ROIC)	-32.54%	-28.78%	-141.47%	-191.95%	-144.57%	-89.13%
Return on Capital Employed (ROCE)	-13.04%	-14.98%	-64.48%	-68.01%	-54.07%	-34.17%
FCF Yield	0.72%	1.09%	-	-	-	-
Buyback Yield / Dilution	-10.28%	-13.09%	-6.22%	-16.48%	-6.56%	-25.86%
Total Shareholder Return	-10.28%	-13.09%	-6.22%	-16.48%	-6.56%	-25.86%

SEC Filings: 10-K · 10-Q